drug
1568 prediction markets tagged with “drug”
| # | Market | Platform | Yes | Volume | End Date |
|---|---|---|---|---|---|
| 1 | FDA approves Retatrutide this year? | polymarket | 11¢ | $569K | Dec 31 |
| 2 | FDA approves Arcutis' Zoryve cream? | polymarket | 88¢ | $4K | Jun 29 |
| 3 | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | polymarket | 65¢ | $4K | Jun 18 |
| 4 | FDA approves Unicycive's Oxylanthanum carbonate? | polymarket | 78¢ | $3K | Jun 29 |
| 5 | FDA approves Viridian Therapeutics' Veligrotug? | polymarket | 68¢ | $3K | Jun 30 |
| 6 | FDA approves Arcalyst technology transfer? | polymarket | 72¢ | $2K | Jun 19 |
| 7 | FDA approves Ionis' Olezarsen? | polymarket | 88¢ | $2K | Jun 30 |
| 8 | FDA approves Merck's Welireg + Keytruda or Keytruda Qlex? | polymarket | 80¢ | $297 | Jun 19 |
| 9 | FDA approves Daraxonrasib this year? | polymarket | 66¢ | $66 | Dec 31 |